longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

10X Genomics

TXG

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -156.16, below the reasonable range, cheaper than 93.17% of the time in the past 5 years, and the industry ranks 57/59, the industry Median -1.75.

-156.16xP/E
$90.04Stock price
$-0.58Earnings per share
-156.16xP/E
Stock price$90.04Earnings per share$-0.58

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-27.59x
Typical range
-57.42x–-10.63x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
LZAGYUSLonza
-354.62x--$48.87B
TEMUSTempus AI
-58.23x1.23%$14.82B
CRLUSCharles River Laboratorie
-59.25x229.32%$14.13B
TXGUS10X Genomics
-156.16x107.32%$11.73B
AVTRUSAvantor
-17.83x142.83%$10.31B
BRKRUSBruker
-91.94x7.71%$9.83B
ABCLUSAbcellera Biologics
-29.17x36.73%$4.80B
ADPTUSAdaptive Biotechnologies
-71.91x39.25%$4.59B
ALMRUSAlamar Biosciences
-45.62x80.55%$2.27B
MRVIUSMaravai LifeSciences
-25.67x65.83%$1.99B
FTREUSFortrea
-22.03x93.77%$1.88B
PSNLUSPersonalis
-16.29x20.05%$1.75B
AZTAUSAzenta
-12.22x180.77%$1.50B
CYRXUSCryoport
-19.33x156.25%$877.24M
DNAUSGinkgo Bioworks
-2.77x35.20%$805.39M
CTKBUSCytek Biosciences
-9.29x33.98%$748.70M
OABIUSOmniAb
-15.57x35.96%$689.15M
EVOUSEvotec SE
-2.55x381.02%$582.54M
PACBUSPacific Biosc California
-4.33x75.82%$568.82M
TKNOUSAlpha Teknova
-29.07x5.80%$487.49M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.